PuSH - Publikationsserver des Helmholtz Zentrums München

Reißig, S.* ; Tang, Y.* ; Nikolaev, A.* ; Gerlach, K.* ; Wolf, C. ; Davari, K. ; Gallus, C. ; Masri, J.* ; Mufazalov, I.A.* ; Neurath, M.F.* ; Wunderlich, F.T.* ; Schattenberg, J.M.* ; Galle, P.R.* ; Weigmann, B.* ; Waisman, A.* ; Glasmacher, E. ; Hövelmeyer, N.*

Elevated levels of Bcl-3 inhibits Treg development and function resulting in spontaneous colitis.

Nat. Commun. 8:15069 (2017)
Verlagsversion Forschungsdaten DOI PMC
Open Access Gold
Creative Commons Lizenzvertrag
Bcl-3 is an atypical NF-κB family member that regulates NF-κB-dependent gene expression in effector T cells, but a cell-intrinsic function in regulatory T (Treg) cells and colitis is not clear. Here we show that Bcl-3 expression levels in colonic T cells correlate with disease manifestation in patients with inflammatory bowel disease. Mice with T-cell-specific overexpression of Bcl-3 develop severe colitis that can be attributed to defective Treg cell development and function, leading to the infiltration of immune cells such as pro-inflammatory γδT cells, but not αβ T cells. In Treg cells, Bcl-3 associates directly with NF-κB p50 to inhibit DNA binding of p50/p50 and p50/p65 NF-κB dimers, thereby regulating NF-κB-mediated gene expression. This study thus reveals intrinsic functions of Bcl-3 in Treg cells, identifies Bcl-3 as a potential prognostic marker for colitis and illustrates the mechanism by which Bcl-3 regulates NF-κB activity in Tregs to prevent colitis.
Impact Factor
Scopus SNIP
Web of Science
Times Cited
Scopus
Cited By
Altmetric
12.124
2.995
13
15
Tags
Anmerkungen
Besondere Publikation
Auf Hompepage verbergern

Zusatzinfos bearbeiten
Eigene Tags bearbeiten
Privat
Eigene Anmerkung bearbeiten
Privat
Auf Publikationslisten für
Homepage nicht anzeigen
Als besondere Publikation
markieren
Publikationstyp Artikel: Journalartikel
Dokumenttyp Wissenschaftlicher Artikel
Schlagwörter Nf-kappa-b; Inflammatory-bowel-disease; Regulatory T-cells; Chronic Intestinal Inflammation; Foxp3 Transcription Factor; Oncoprotein Bcl-3; Crohns-disease; Targeted Disruption; Ulcerative-colitis; P50 Homodimers
Sprache englisch
Veröffentlichungsjahr 2017
HGF-Berichtsjahr 2017
ISSN (print) / ISBN 2041-1723
e-ISSN 2041-1723
Zeitschrift Nature Communications
Quellenangaben Band: 8, Heft: , Seiten: , Artikelnummer: 15069 Supplement: ,
Verlag Nature Publishing Group
Verlagsort London
Begutachtungsstatus Peer reviewed
POF Topic(s) 90000 - German Center for Diabetes Research
Forschungsfeld(er) Helmholtz Diabetes Center
PSP-Element(e) G-501900-226
PubMed ID 28452361
Scopus ID 85038939745
Erfassungsdatum 2017-07-05